Optos plc‘s sales during the first three quarters of fiscal 2009 slipped 1 percent to $72.2 million, but its strategy to boost pay-per-patient revenues gained traction.
The British retinal imaging firm, which has operations in Marlborough, Mass., said its pay-per-patient revenues during the nine months ended June 30 rose 3 percent to $70 million, compared with $68.2 million during the same period last year, as it put a new sales strategy in place to shift its focus from large capital equipment sales.
Optos, which posted sales of $73.1 million during the first nine months of fiscal 2008, also cited a deal with eyecare benefits provider VSP Global, the largest eye-health insurance provider in the United States. The company said it expects the agreement to “help drive the adoption of optomap eye examinations amongst both VSP members and doctors.”
CEO Roy Davis added that the company slashed its overhead costs by nearly 20 percent and is on target to meet its full-year guidance.